Contributions of endothelium-derived relaxing factors to control of hindlimb blood flow in the mouse in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 2, 2007, Pages

  Fitzgerald, Sharyn M ^a   Bashari, Homaira ^a   Cox, Jessica A ^a   Parkington, Helena C ^a   Evans, Roger G ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Endothelium derived hyperpolarizing factor; Nitric oxide; Prostanoids

Indexed keywords

ACETYLCHOLINE; APAMIN; CHARYBDOTOXIN; DIETHLYAMINE NONOATE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ARTERY CATHETER; ARTICLE; BLOOD VESSEL TONE; CAROTID ARTERY; CONTROLLED STUDY; DRUG DOSE TITRATION; FEMORAL ARTERY; HEMODYNAMICS; HINDLIMB; HYPEREMIA; IN VIVO STUDY; JUGULAR VEIN; LEG BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRASOUND; VASODILATATION;

ACETYLCHOLINE; ANIMALS; APAMIN; BIOLOGICAL FACTORS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CHARYBDOTOXIN; CYCLOOXYGENASE INHIBITORS; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; ENZYME INHIBITORS; HEART RATE; HINDLIMB; INDOMETHACIN; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; VASODILATION; VASODILATOR AGENTS;

EID: 34547877614     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00072.2007     Document Type: Article

References (32)

1. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 91: 7583-7587, 1994.
2. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94: 3341-3347, 1996.
3. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994.
4. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci USA 97: 9747-9752, 2000.
5. Coleman HA, Tare M, Parkington HC. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. Clin Exp Pharmacol Physiol 31: 641-649, 2004.
6. De Vriese AS, Van de Voorde J, Lameire NH. Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase- independent renal vasodilation. Kidney Int 61: 177-185, 2002.
7. Ding H, Kubes P, Triggle C. Potassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase. Br J Pharmacol 129: 1194-1200, 2000.
8. Fitzgerald SM, Kemp-Harper BK, Tare M, Parkington HC. Role of endothelium-derived hyperpolarizing factor in endothelial dysfunction during diabetes. Clin Exp Pharmacol Physiol 32: 482-487, 2005.
9. Halcox JP, Narayanan S, Cramer-Joyce L, Mincemoyer R, Quyyumi AA. Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol Heart Circ Physiol 280: H2470-H2477, 2001.
10. Harrington LS, Falck JR, Mitchell JA. Not so EEZE: the 'EDHF' antagonist 14,15 epoxyeicosa-5(Z)-enoic acid has vasodilator properties in mesenteric arteries. Eur J Pharmacol 506: 165-168, 2004.
11. Huang A, Sun D, Smith CJ, Connetta JA, Shesely EG, Koller A, Kaley G. In eNOS knockout mice skeletal muscle arteriolar dilation to acetylcholine is mediated by EDHF. Am J Physiol Heart Circ Physiol 278: H762-H768, 2000.
12. Imig JD. Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am J Physiol Renal Physiol 289: F496-F503, 2005.
13. Inokuchi K, Hirooka Y, Shimokawa H, Sakai K, Kishi T, Ito K, Kimura Y, Takeshita A. Role of endothelium-derived hyperpolarizing factor in human forearm circulation. Hypertension 42: 919-924, 2003.
14. Krummen S, Falck JR, Thorin E. Two distinct pathways account for EDHF-dependent dilatation in the gracilis artery of dyslipidaemic hApoB+/+ mice. Br J Pharmacol 145: 264-270, 2005.
15. Loyaga-Rendon RY, Sakamoto S, Aso T, Iwasaki-Kurashige K, Takahashi R, Azuma H. Mediators involved in decreasing peripheral vascular resistance with carbachol in the rat hind limb perfusion model. J Pharm Sci 98: 263-274, 2005.
16. Ludbrook J. On making multiple comparisons in clinical and experimental pharmacology and physiology. Clin Exp Pharmacol Physiol 18: 379-392, 1991.
17. Matsuda H, Hayashi K, Wakino S, Kubota E, Honda M, Tokuyama H, Takamatsu I, Tatematsu S, Saruta T. Role of endothelium-derived hyperpolarizing factor in ACE inhibitor-induced renal vasodilation in vivo. Hypertension 43: 603-609, 2004.
18. Nishikawa Y, Stepp DW, Chilian WM. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation. Am J Physiol Heart Circ Physiol 277: H1252-H1259, 1999.
19. Nishikawa Y, Stepp DW, Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol 279: H459-H465, 2000.
20. Parkington HC, Chow JA, Evans RG, Coleman HA, Tare M. Role for endothelium-derived hyperpolarizing factor in vascular tone in rat mesenteric and hindlimb circulations in vivo. J Physiol 542: 929-937, 2002.
21. Rajapakse NW, Oliver JJ, Evans RG. Nitric oxide in responses of regional kidney blood flow to vasoactive agents in anesthetized rabbits. J Cardiovasc Pharmacol 40: 210-219, 2002.
22. Rajapakse NW, Roman RJ, Falck JR, Oliver JJ, Evans RG. Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids. Am J Physiol Regul Integr Comp Physiol 287: R181-R187, 2004.
23. Rajapakse NW, Sampson AK, Eppel GA, Evans RG. Angiotensin II and nitric oxide in neural control of intrarenal blood flow. Am J Physiol Regul Integr Comp Physiol 289: R745-R754, 2005.
24. Schildmeyer LA, Bryan RM Jr. Effect of NO on EDHF response in rat middle cerebral arteries. Am J Physiol Heart Circ Physiol 282: H734-H738, 2002.
25. Schrage WG, Dietz NM, Eisenach JH, Joyner MJ. Agonist-dependent variability of contributions of nitric oxide and prostaglandins in human skeletal muscle. J Appl Physiol 98: 1251-1257, 2005.
26. Scotland RS, Madhani M, Chauhan S, Moncada S, Andresen J, Nilsson H, Hobbs AJ, Ahluwalia A. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 111: 796-803, 2005.
27. + channel. Circ Res 99: 537-544, 2006.
28. Taddei S, Ghiadoni L, Virdis A, Buralli S, Salvetti A. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation 100: 1400-1405, 1999.
29. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 346: 69-71, 1990.
30. Triggle CR, Hollenberg M, Anderson TJ, Ding H, Jiang Y, Ceroni L, Wiehler WB, Ng ES, Ellis A, Andrews K, McGuire JJ, Pannirselvam M. The endothelium in health and disease-a target for therapeutic intervention. J Smooth Muscle Res 39: 249-267, 2003.
31. Udosen IT, Jiang H, Hercule HC, Oyekan AO. Nitric oxide-epoxygenase interactions and arachidonate-induced dilation of rat renal microvessels. Am J Physiol Heart Circ Physiol 285: H2054-H2063, 2003.
32. Vanhoutte PM. Endothelial control of vasomotor function: from health to coronary disease. Circ J 67: 572-575, 2003.